Compare INOD & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INOD | LGND |
|---|---|---|
| Founded | 1988 | 1987 |
| Country | United States | United States |
| Employees | 3000 | 68 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 1996 | N/A |
| Metric | INOD | LGND |
|---|---|---|
| Price | $101.91 | $237.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $100.00 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 3.2M | 176.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.37 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $86,775,000.00 | N/A |
| Revenue This Year | $38.42 | $1.25 |
| Revenue Next Year | $27.03 | $19.41 |
| P/E Ratio | $289.29 | ★ $76.27 |
| Revenue Growth | ★ 9.84 | N/A |
| 52 Week Low | $34.23 | $103.43 |
| 52 Week High | $125.14 | $247.38 |
| Indicator | INOD | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 61.82 |
| Support Level | $40.21 | $199.97 |
| Resistance Level | $114.77 | $247.38 |
| Average True Range (ATR) | 10.55 | 7.00 |
| MACD | -0.15 | 1.15 |
| Stochastic Oscillator | 38.47 | 91.53 |
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.